Treu Jesse I
Director at ALDX; Director at VCYT; 10% owner at Evoke Pharma Inc, and 10 more
- Sold, on record
- $74.1M
- Dollars the filings state
- Form 4 sales
- 45
- Latest Mar 26, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 13
- Filed as an executive or holder
Companies
- ALDXAldeyra Therapeutics, Inc.Director
- VCYTVERACYTE, INC.Director
- Evoke Pharma Inc10% owner
- ALIMERA SCIENCES INC10% owner
- CADENCE PHARMACEUTICALS INC10% owner
- REVA Medical, Inc.10% owner
- Somaxon Pharmaceuticals, Inc.Director
- NOVACEA INC10% owner
- Volcano CORP10% owner
- SENORX INCDirector
- Orexigen Therapeutics, Inc.10% owner
- Northstar Neuroscience, Inc.Director
- VNDAVanda Pharmaceuticals Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- REVA Medical, Inc.1.7M shares
- Volcano CORP1.6M shares
- VCYT1.6M shares
- Somaxon Pharmaceuticals, Inc.1.4M shares
- Northstar Neuroscience, Inc.416,586 shares
- CADENCE PHARMACEUTICALS INC382,321 shares
- NOVACEA INC274,500 shares
- ALDX96,743 shares
- Orexigen Therapeutics, Inc.21,000 shares
- Evoke Pharma Inc16,931 shares
- VNDA12,900 shares
- ALIMERA SCIENCES INC6,973 shares
- SENORX INC2,750 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CADENCE PHARMACEUTICALS INCUnusualApr 15 2013
Sold 71,578 shares at $6.62 ($474k)
Treu Jesse I, 10% owner
Sold 1% of holdings ($48.9M position)7.3M shares left20.4x usual sizeFiling
- 2 Form 4 sale ALIMERA SCIENCES INCPlan not statedJun 11 +57 days
Sold 59 shares at $5.00 ($295)
Treu Jesse I, 10% owner
Sold 0.1% of holdings ($202k position)40,248 shares leftFirst sale on recordFiling
- 3 Form 4 sale Evoke Pharma IncPlan not statedAug 18 +798 days
Sold 11,836 shares at $7.02 ($83k)
Treu Jesse I, 10% owner
Sold 1.1% of holdings ($7.5M position)1.1M shares leftFirst sale on recordFiling
- 4 Form 4 sale Evoke Pharma IncPlan not statedApr 27 +253 days
Sold 5,095 shares at $5.07 ($26k)
Treu Jesse I, 10% owner
Sold 0.5% of holdings ($4.8M position)950,403 shares leftFiling
- 5 Form 4 sale VCYTPlan not statedMay 16 +384 days
Sold 2,226 shares at $8.08 ($18k)
Treu Jesse I, Director
Sold 9.8% of holdings ($184k position)20,504 shares leftFirst sale on recordFiling
- 6 Form 4 sale VCYTUnusualAug 1 +442 days
Sold 500,000 shares at $10.83 ($5.4M)
Treu Jesse I, Director
Sold 96.7% of holdings ($5.6M position)16,804 shares leftFiling
- 7 Form 4 sale VCYTUnusualMar 4 +215 days
Sold 1.1M shares at $20.37 ($21.4M)
Treu Jesse I, Director
Sold 100% of holdings ($21.4M position)0 shares leftFiling
- 8 Form 4 sale ALDXUnusualMar 26 +22 days
Sold 96,743 shares at $10.01 ($968k)
Treu Jesse I, Director
Sold 91.7% of holdings ($1.1M position)8,763 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (45)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2019 | ALDX | Director | Form 4 sale | 96,743 | $968k | 91.7% | Unusual | SEC |
| Mar 4, 2019 | VCYT | Director | Form 4 sale | 1.1M | $21.4M | 100.0% | Unusual | SEC |
| Aug 1, 2018 | VCYT | Director | Form 4 sale | 500,000 | $5.4M | 96.7% | Unusual | SEC |
| May 16, 2017 | VCYT | Director | Form 4 sale | 2,226 | $18k | 9.8% | Plan not stated | SEC |
| Apr 27, 2016 | Evoke Pharma Inc | 10% owner | Form 4 sale | 5,095 | $26k | 0.5% | Plan not stated | SEC |
| Aug 18, 2015 | Evoke Pharma Inc | 10% owner | Form 4 sale | 11,836 | $83k | 1.1% | Plan not stated | SEC |
| Jun 11, 2013 | ALIMERA SCIENCES INC | 10% owner | Form 4 sale | 59 | $295 | 0.1% | Plan not stated | SEC |
| Apr 15, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 71,578 | $474k | 1.0% | Unusual | SEC |
| Mar 18, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 583 | $3k | 0.7% | Plan not stated | SEC |
| Mar 18, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 54,455 | $285k | 0.7% | Unusual | SEC |
| Mar 14, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 422 | $2k | 0.5% | Plan not stated | SEC |
| Mar 14, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 216 | $1k | 0.5% | Plan not stated | SEC |
| Mar 8, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 591 | $3k | 0.7% | Plan not stated | SEC |
| Mar 4, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 12,780 | $64k | 0.5% | Plan not stated | SEC |
| Feb 20, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 6,160 | $31k | 0.1% | Plan not stated | SEC |
| Feb 19, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 222 | $1k | 0.5% | Plan not stated | SEC |
| Feb 19, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 13,043 | $65k | 0.5% | Plan not stated | SEC |
| Feb 14, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 26,870 | $134k | 0.3% | Plan not stated | SEC |
| Jan 25, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 153,547 | $834k | 1.9% | Plan not stated | SEC |
| Jan 25, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 850 | $5k | 1.9% | Plan not stated | SEC |
| Jan 23, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 684 | $3k | 1.5% | Plan not stated | SEC |
| Jan 23, 2013 | CADENCE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 40,320 | $205k | 1.5% | Plan not stated | SEC |
| Mar 23, 2012 | REVA Medical, Inc. | 10% owner | Form 4 sale | 1.7M | $8.7M | 95.2% | Unusual | SEC |
| Jun 2, 2011 | ALIMERA SCIENCES INC | 10% owner | Form 4 sale | 6,914 | $56k | 14.5% | Plan not stated | SEC |
| Dec 18, 2009 | Somaxon Pharmaceuticals, Inc. | Director | Form 4 sale | 896,766 | $937k | 100.0% | Unusual | SEC |
| Dec 14, 2009 | Somaxon Pharmaceuticals, Inc. | Director | Form 4 sale | 35,000 | $40k | 78.8% | Unusual | SEC |
| Dec 11, 2009 | Somaxon Pharmaceuticals, Inc. | Director | Form 4 sale | 465,500 | $535k | 97.9% | Unusual | SEC |
| Jan 30, 2009 | NOVACEA INC | 10% owner | Form 4 sale | 250,000 | $239k | 78.6% | Unusual | SEC |
| Jul 16, 2008 | Volcano CORP | 10% owner | Form 4 sale | 19,357 | $280k | 23.6% | Plan not stated | SEC |
| Apr 8, 2008 | Volcano CORP | 10% owner | Form 4 sale | 16,832 | $218k | 17.7% | Plan not stated | SEC |
| Feb 26, 2008 | SENORX INC | Director | Form 4 sale | 2,750 | $23k | 11.1% | Plan not stated | SEC |
| Nov 27, 2007 | Orexigen Therapeutics, Inc. | 10% owner | Form 4 sale | 21,000 | $300k | 20.0% | Plan not stated | SEC |
| Jun 6, 2007 | NOVACEA INC | 10% owner | Form 4 sale | 24,500 | $276k | 25.0% | Plan not stated | SEC |
| Jun 5, 2007 | Somaxon Pharmaceuticals, Inc. | Director | Form 4 sale | 3,500 | $49k | 23.2% | Plan not stated | SEC |
| Jun 1, 2007 | Volcano CORP | 10% owner | Form 4 sale | 29,186 | $601k | 100.0% | Unusual | SEC |
| May 18, 2007 | Volcano CORP | 10% owner | Form 4 sale | 25,247 | $486k | 21.6% | Plan not stated | SEC |
| May 17, 2007 | Somaxon Pharmaceuticals, Inc. | Director | Form 4 sale | 4,297 | $62k | 22.2% | Plan not stated | SEC |
| May 15, 2007 | Northstar Neuroscience, Inc. | Director | Form 4 sale | 379,000 | $5M | 100.0% | Unusual | SEC |
| May 4, 2007 | Northstar Neuroscience, Inc. | Director | Form 4 sale | 15,971 | $208k | 100.0% | Unusual | SEC |
| Mar 5, 2007 | Northstar Neuroscience, Inc. | Director | Form 4 sale | 9,085 | $99k | 36.3% | Unusual | SEC |
| Dec 21, 2006 | Somaxon Pharmaceuticals, Inc. | Director, 10% owner | Form 4 sale | 6,459 | $87k | 25.0% | Plan not stated | SEC |
| Dec 12, 2006 | VNDA | 10% owner | Form 4 sale | 12,900 | $330k | 38.0% | Unusual | SEC |
| Dec 6, 2006 | Volcano CORP | 10% owner | Form 4 sale | 1.5M | $25.3M | 93.1% | Unusual | SEC |
| Nov 6, 2006 | Northstar Neuroscience, Inc. | Director | Form 4 sale | 12,530 | $164k | 33.3% | Unusual | SEC |
| Sep 18, 2006 | Somaxon Pharmaceuticals, Inc. | Director, 10% owner | Form 4 sale | 6,459 | $84k | 20.0% | Plan not stated | SEC |